caloreen has been researched along with epidermal growth factor in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duncan, R; Ferguson, EL; Hardwicke, J; Moseley, R; Stephens, P; Thomas, DW | 1 |
| Park, K | 1 |
| Duncan, R; Harding, K; Hardwicke, J; Moseley, R; Stephens, P; Thomas, DW | 1 |
| Bell, A; Duncan, R; Hardwicke, JT; Hart, J; Moseley, R; Thomas, DW | 1 |
4 other study(ies) available for caloreen and epidermal growth factor
| Article | Year |
|---|---|
Dextrin-rhEGF conjugates as bioresponsive nanomedicines for wound repair.
Topics: alpha-Amylases; Biocatalysis; Cell Line; Cell Line, Tumor; Cell Proliferation; Delayed-Action Preparations; Dextrins; Drug Delivery Systems; Drug Stability; Epidermal Growth Factor; ErbB Receptors; Humans; Keratinocytes; Kinetics; Leukocyte Elastase; Molecular Weight; Nanomedicine; Phosphorylation; Prodrugs; Recombinant Proteins; Spectroscopy, Fourier Transform Infrared; Succinic Anhydrides; Wound Healing | 2008 |
Bioresponsive drug delivery for regenerative medicine.
Topics: alpha-Amylases; Cell Line; Cell Line, Tumor; Cell Proliferation; Delayed-Action Preparations; Dextrins; Drug Delivery Systems; Epidermal Growth Factor; Humans; Keratinocytes; Leukocyte Elastase; Regenerative Medicine; Wound Healing | 2008 |
Bioresponsive dextrin-rhEGF conjugates: in vitro evaluation in models relevant to its proposed use as a treatment for chronic wounds.
Topics: alpha-Amylases; Cell Line; Cell Movement; Cell Proliferation; Cells, Cultured; Dextrins; Enzyme-Linked Immunosorbent Assay; Epidermal Growth Factor; Fibroblasts; Humans; Keratinocytes; Recombinant Proteins; Wound Healing | 2010 |
The effect of dextrin-rhEGF on the healing of full-thickness, excisional wounds in the (db/db) diabetic mouse.
Topics: alpha-Amylases; Animals; Dextrins; Diabetes Complications; Drug Carriers; Epidermal Growth Factor; Granulation Tissue; Humans; Male; Mice; Mice, Mutant Strains; Neovascularization, Physiologic; Recombinant Proteins; Skin; Wound Healing | 2011 |